Merrill Matthews, Ph.D., is a resident scholar with the Institute for Policy Innovation, a research-based, public policy “think tank.” He is a health policy expert and opinion contributor at The Hill. He also serves on the Texas Advisory Committee of the U.S. Commission on Civil Rights.
Dr. Matthews is a past president of the Health Economics Roundtable for the National Association for Business Economics, the largest trade association of business economists. Dr. Matthews also served for 10 years as the medical ethicist for the University of Texas Southwestern Medical Center’s Institutional Review Board for Human Experimentation, co-author of On the Edge: America Faces the Entitlements Cliff, and has contributed chapters to several books, including Physician Assisted Suicide: Expanding the Debate and The 21st Century Health Care Leader and Stop Paying the Crooks (on Medicare fraud).
He has been published in numerous journals and newspapers, including The Wall Street Journal, Investor’s Business Daily, Barron’s, USA Today, Forbes magazine and the Washington Times. He was an award-winning political analyst for the USA Radio Network.
Dr. Matthews received his Ph.D. in Humanities from the University of Texas at Dallas.
Comparing Responses to Two Prominent GOP Sex Scandals
The Florida GOP’s response to allegations against Ziegler could be considered an example of an effort to take the moral high ground. But then how to explain many Republicans’ lack of interest in the more numerous, and in some cases more serious, allegations against Trump?
What Donald Trump Can Learn from Switzerland
The Swiss understand that eliminating tariffs helps consumers and the economy. Donald Trump hasn't learned that lesson.
A 'Boycott, Divestment, Sanctions' Movement Conservatives Can Support
Colleges and universities need to step up and ensure the safety of their students—all students. If that means getting the federal government to “divest” from those that don’t, it will send an important message and save some taxpayer money.
What If No One Wants to Buy U.S. Debt?
Investors, domestic and foreign, have been willing to buy U.S. debt so far, but there are signs of change.
When Government Goes Marching In, Innovation Marches Out
Biden doesn’t just target the pharmaceutical industry, he’s threatening any and every industry, academic institution and researcher that receives even a whiff of federal funding.
Are You Ready for MAGAnomics? Is the Country?
Biden has decided to attack "MAGAnomics," though it isn't clear exactly what that is.
Trump's Right, ObamaCare Sucks: Here's Why
ObamaCare has failed to achieve any of President Barack Obama’s vaunted promises. As we approach the law’s 10-year anniversary let’s revisit some of its failed promises.
Shocker: We Agree with the Unions on This One
It seems crime does pay; what apparently doesn't pay in an employer that cans an employee for trying to stop massive retail theft.
Another Way Republicans and Democrats Can Punish Rogue Members
The benefit of expulsion from the Conference or Caucus, rather than expulsion from the House, is it is easier to achieve.
Bidenomics Is Xinomics with American Characteristics
President Joe Biden has been abandoning the U.S. version of free market capitalism that Deng admired and increasingly embracing variations of Xi’s policies. Call it Xinomics with American characteristics.